Legend Biotech Current Valuation vs. Price To Sales
| LEGN Stock | USD 37.90 3.73 8.96% |
For Legend Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Legend Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Legend Biotech Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Legend Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Legend Biotech Corp over time as well as its relative position and ranking within its peers.
Legend |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 2.851 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.28) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Legend Biotech Corp Price To Sales vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Legend Biotech's current stock value. Our valuation model uses many indicators to compare Legend Biotech value to that of its competitors to determine the firm's financial worth. Legend Biotech Corp is rated below average in current valuation category among its peers. It is rated below average in price to sales category among its peers . The ratio of Current Valuation to Price To Sales for Legend Biotech Corp is about 461,211,837 . At this time, Legend Biotech's Price To Sales Ratio is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Legend Biotech's earnings, one of the primary drivers of an investment's value.Legend Current Valuation vs. Competition
Legend Biotech Corp is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 146.42 Billion. Legend Biotech holds roughly 6.77 Billion in current valuation claiming about 5% of equities under Health Care industry.
Legend Price To Sales vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Legend Biotech |
| = | 6.77 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Legend Biotech |
| = | 14.68 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Legend Price To Sales Comparison
Legend Biotech is currently under evaluation in price to sales category among its peers.
Legend Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Legend Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Legend Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Legend Biotech's change in net profit over the period of time. It can combine multiple indicators of Legend Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 98.9 M | 94 M | |
| Operating Income | -439.5 M | -417.5 M | |
| Income Before Tax | -520.1 M | -494.1 M | |
| Total Other Income Expense Net | -80.6 M | -76.6 M | |
| Net Loss | -401.7 M | -381.6 M | |
| Net Loss | -518.3 M | -492.3 M | |
| Income Tax Expense | -1.9 M | -1.8 M | |
| Net Interest Income | 21.2 M | 22.3 M | |
| Interest Income | 42.1 M | 44.2 M | |
| Net Loss | -509.3 M | -483.8 M | |
| Change To Netincome | 39.3 M | 55.1 M | |
| Net Loss | (2.94) | (3.09) | |
| Income Quality | 0.76 | 0.80 | |
| Net Income Per E B T | 1.00 | 1.17 |
Legend Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Legend Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Legend Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Legend Biotech's important profitability drivers and their relationship over time.
Use Legend Biotech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will appreciate offsetting losses from the drop in the long position's value.Legend Biotech Pair Trading
Legend Biotech Corp Pair Trading Analysis
The ability to find closely correlated positions to Legend Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend Biotech Corp to buy it.
The correlation of Legend Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend Biotech Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Legend Biotech position
In addition to having Legend Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Synthetics Thematic Idea Now
Synthetics
Companies involved in production of silicon and other synthetic products . The Synthetics theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Synthetics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
To fully project Legend Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Legend Biotech Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Legend Biotech's income statement, its balance sheet, and the statement of cash flows.